biotech peptides retatrutide (6mg) Pure lab peptides Retatrutide 10mg

This article is for educational purposes only

The Phase 3 results are promising, but most of the programme is still running, and the long-term cardiovascular outcomes data wont be available until 2028 at the earliest

Correction Jan

By improving insulin sensitivity, blood glucose control, blood pressure and overall metabolic health, GLP-1 agonists may help address several underlying drivers of kidney stone disease

I am 53, female, and now 188

Since background BMI can be largely different between races, caution is needed when interpreting and applying the results, including combination use with SGLT2is and finerenone